Active substance
Propoxyphene
- US FDA 30
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DARVON | 32MG; 65MG | capsule · oral | XANODYNE PHARM | Discontinued | 16 Aug 1957 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | PAR PHARM | Discontinued | 30 Nov 1971 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | WATSON LABS | Discontinued | 7 Aug 1972 |
| DOLENE | 65MG | capsule · oral | HERITAGE PHARMS INC | Discontinued | 15 Sep 1972 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | SANDOZ | Discontinued | 18 Oct 1972 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | NEXGEN PHARMA INC | Discontinued | 2 Nov 1972 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | MUTUAL PHARM | Discontinued | 18 Dec 1972 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | PUREPAC PHARM | Discontinued | 15 Jan 1973 |
| KESSO-GESIC | 65MG | capsule · oral | MK LABS | Discontinued | 6 Jun 1973 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | WEST WARD | Discontinued | 20 Jun 1973 |
| PROPOXYPHENE HYDROCHLORIDE | 32MG; 65MG | capsule · oral | ROXANE | Discontinued | 13 Aug 1973 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | IMPAX LABS | Discontinued | 23 Oct 1973 |
| PROPOXYPHENE HYDROCHLORIDE | 32MG | capsule · oral | IVAX SUB TEVA PHARMS | Discontinued | 11 Dec 1973 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | SANDOZ | Discontinued | 27 Aug 1974 |
| PROPOXYPHENE HYDROCHLORIDE | 32MG | capsule · oral | SANDOZ | Discontinued | 9 Sep 1974 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | SANDOZ | Discontinued | 13 Feb 1975 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | PVT FORM | Discontinued | 20 Aug 1976 |
| PROPOXYPHENE HYDROCHLORIDE | 32MG | capsule · oral | PVT FORM | Discontinued | 20 Aug 1976 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | WATSON LABS | Discontinued | 8 Nov 1976 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | SANDOZ | Discontinued | 7 Jul 1980 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | TEVA | Discontinued | 22 Oct 1984 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | MYLAN | Discontinued | 16 Dec 2004 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | VINTAGE PHARMS | Discontinued | 17 Jul 2009 |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | VALEANT PHARM INTL | Discontinued | |
| PROPOXYPHENE HYDROCHLORIDE | 65MG | capsule · oral | ALRA | Discontinued |
5 more — full table
Safety signals and safety-related labeling changes
- MHRA 11 Dec 2014 (Dextro)propoxyphene: new studies confirm cardiac risks
(Dextro)propoxyphene can have serious effects on the electrical activity of the heart (resulting in prolongation of the P-R and Q-T intervals, and widened QRS complexes), even at normal therapeutic doses.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.